Trials / Unknown
UnknownNCT01784107
A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Phase 1 : To evaluate MTD(Maximal tolerated dose)and DLT(Dose limiting Toxicity) of Belotecan and Ifosfamide. Phase 2 : To analyse efficacy and toxicity of Belotecan and Ifosfamide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Belotecan and Ifosfamide |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2018-07-01
- First posted
- 2013-02-05
- Last updated
- 2016-02-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01784107. Inclusion in this directory is not an endorsement.